Do current data justify the framing of respiratory fluoroquinolones and lascufloxacin in the 2024 JRS adult pneumonia guideline digest?

Respiratory Investigation 2026

View at publisher

Authors: Kazuki Miyaue

DOI: 10.1016/j.resinv.2026.101433

Cited by: 1

References: 4

Fields of Study & Subjects

Antibiotics Pharmacokinetics and Efficacy Nosocomial Infections in ICU Pneumonia and Respiratory Infections

References 4